Iveric Bio Building Ophthalmology Commercial Team Ahead Of First Launch

 
• By Jessica Merrill

CEO Glenn Sblendorio talked to Scrip about the company's plans to transition into a commercial-stage company after completing an NDA submission for its geographic atrophy drug in December.

building blocks
Iveric Bio is building commercially • Source: Shutterstock

More from Sensory

More from Therapy Areas